SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-20-009216
Filing Date
2020-06-10
Accepted
2020-06-10 16:49:07
Documents
9
Effectiveness Date
2020-06-10

Document Format Files

Seq Description Document Type Size
1 S-8 xfor-2020062020xsx8.htm S-8 104486
2 EX-5.1 x4-sx8x51opinionjune2020.htm EX-5.1 13902
3 EX-23.1 xfor_6102020xs-8xconsent.htm EX-23.1 2238
4 EX-99.1 xfor_06102020xamendedandre.htm EX-99.1 123331
5 EX-99.6 x4-2017planxformofperforma.htm EX-99.6 69195
6 image_01.jpg GRAPHIC 8359
7 image_02.jpg GRAPHIC 8359
8 image_21.jpg GRAPHIC 173
9 image_31.jpg GRAPHIC 1810
  Complete submission text file 0001628280-20-009216.txt   340317
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239082 | Film No.: 20955241
SIC: 2836 Biological Products, (No Diagnostic Substances)